Total Payments
$10,851
2024 Payments
$1,078
Companies
51
Transactions
477
Medicare Patients
4,148
Medicare Billing
$376,823
Payment Breakdown by Category
Food & Beverage$9,005 (83.0%)
Travel$1,536 (14.2%)
Education$310.72 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,005 | 460 | 83.0% |
| Travel and Lodging | $1,536 | 5 | 14.2% |
| Education | $310.72 | 12 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $1,266 | 8 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,175 | 61 | $0 (2024) |
| ABIOMED | $864.54 | 21 | $0 (2024) |
| Amgen Inc. | $800.40 | 44 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $770.38 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $562.66 | 34 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $497.12 | 28 | $0 (2023) |
| BIOTRONIK INC. | $490.14 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $465.29 | 23 | $0 (2024) |
| PFIZER INC. | $436.79 | 28 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,078 | 41 | ABIOMED ($379.33) |
| 2023 | $1,270 | 59 | Amgen Inc. ($227.58) |
| 2022 | $1,101 | 60 | Boehringer Ingelheim Pharmaceuticals, Inc. ($195.95) |
| 2021 | $1,549 | 86 | Boehringer Ingelheim Pharmaceuticals, Inc. ($359.58) |
| 2020 | $1,076 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($202.00) |
| 2019 | $1,413 | 76 | Janssen Pharmaceuticals, Inc ($172.15) |
| 2018 | $2,612 | 63 | Philips Electronics North America Corporation ($1,195) |
| 2017 | $752.42 | 36 | BOSTON SCIENTIFIC CORPORATION ($204.85) |
All Payment Transactions
477 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/04/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $29.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.52 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/01/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $34.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/15/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: Cardiovascular | ||||||
| 06/25/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: DIABETES | ||||||
| 06/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 06/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiology | ||||||
| 06/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $38.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Obesity | ||||||
| 05/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $54.88 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $52.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 900 | 1,093 | $343,637 | $83,987 |
| 2022 | 20 | 1,074 | 1,345 | $369,196 | $102,145 |
| 2021 | 18 | 1,367 | 1,785 | $379,315 | $115,855 |
| 2020 | 16 | 807 | 1,002 | $217,463 | $74,836 |
Total Patients
4,148
Total Services
5,225
Medicare Billing
$376,823
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 99 | 99 | $69,733 | $20,097 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 194 | $46,684 | $17,027 | 36.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 124 | 127 | $72,257 | $13,623 | 18.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 91 | 147 | $20,352 | $8,760 | 43.0% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 15 | 16 | $18,437 | $6,832 | 37.1% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $7,297 | $3,006 | 41.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 17 | 33 | $16,674 | $2,817 | 16.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 12 | 48 | $3,537 | $2,154 | 60.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,318 | $1,863 | 35.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 134 | 144 | $22,212 | $1,352 | 6.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 19 | $3,185 | $1,257 | 39.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 121 | 128 | $11,963 | $1,228 | 10.3% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 17 | 17 | $22,786 | $1,211 | 5.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 21 | 22 | $7,832 | $846.75 | 10.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 17 | $4,079 | $841.90 | 20.6% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 11 | 11 | $3,377 | $599.83 | 17.8% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 20 | 21 | $3,155 | $243.10 | 7.7% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 20 | 21 | $4,759 | $228.49 | 4.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 209 | $50,294 | $17,485 | 34.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 117 | 117 | $77,738 | $16,271 | 20.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 66 | 67 | $47,193 | $13,810 | 29.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 34 | 34 | $23,843 | $11,095 | 46.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 13 | 14 | $16,132 | $6,117 | 37.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 31 | 62 | $22,376 | $6,056 | 27.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 27 | 108 | $7,959 | $5,248 | 65.9% |
About Eram Chaudhry
Eram Chaudhry is a Interventional Cardiology healthcare provider based in Silver Creek, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285644880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eram Chaudhry has received a total of $10,851 in payments from pharmaceutical and medical device companies, with $1,078 received in 2024. These payments were reported across 477 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($9,005).
As a Medicare-enrolled provider, Chaudhry has provided services to 4,148 Medicare beneficiaries, totaling 5,225 services with total Medicare billing of $376,823. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Silver Creek, NY
- Active Since 08/08/2006
- Last Updated 06/15/2021
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1285644880
Products in Payments
- Image Guided Therapy Devices _ Coronary (Device) $1,184
- Impella (Device) $864.54
- JARDIANCE (Drug) $720.22
- ENTRESTO (Drug) $698.62
- ELIQUIS (Drug) $662.32
- XARELTO (Drug) $562.66
- Repatha (Biological) $537.63
- LifeVest (Device) $281.88
- PRALUENT (Drug) $276.26
- VERQUVO (Drug) $247.38
- GENERAL - VASCULAR ACCESS (Device) $204.85
- MULTAQ (Drug) $204.13
- STIOLTO RESPIMAT (Drug) $181.17
- PRADAXA (Drug) $168.22
- Quadra Assura CRT Defibrillator (Device) $165.36
- Corlanor (Drug) $138.02
- PRALUENT ALIROCUMAB INJECTION (Biological) $123.11
- NEXLETOL (Drug) $121.06
- FARXIGA (Drug) $106.48
- CAMZYOS (Drug) $99.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.